drugset / Trial / NCT00420823

A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment

NCT00420823

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether Taurine 4g is effective with antipsychotic medication in the treatment of First Episode Psychosis.Taurine may have an effect on cognition and symptoms. We are examining changes in symptoms and cognition over a 3 month period.

Timeline

Start
2007-01
Primary completion
2009-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Taurine Other / unclassified 4 g

Indications